President and CEO of MISONIX Inc. (MSON, Financial) Michael A Jr Mcmanus buys 5,000 shares of MSON on 12/01/2009 at an average price of $1.75 a share.
Misonix, Inc. designs, develops, manufactures, and markets medical, scientific, and industrial ultrasonic equipment, laboratory safety equipment, and air pollution control products. Misonix's ultrasonic platform is the basis for several innovative medical technologies. Misonix has a minority equity position in Focus Surgery, Inc. which uses high intensity focused ultrasound technology to destroy deep-seated cancerous tissues without affecting surrounding healthy tissue. Misonix acquired worldwide rights to use the Focus technology in kidney, liver and breast treatment. Addressing a combined market estimated to be in excess of billion annually, Misonix's proprietary ultrasonic medical devices are used for wound debridement, cosmetic surgery, neurosurgery, laparoscopic surgery, and other surgical and medical applications. Misonix Inc. has a market cap of $12.2 million; its shares were traded at around $1.7401 with and P/S ratio of 0.3.
Misonix, Inc. designs, develops, manufactures, and markets medical, scientific, and industrial ultrasonic equipment, laboratory safety equipment, and air pollution control products. Misonix's ultrasonic platform is the basis for several innovative medical technologies. Misonix has a minority equity position in Focus Surgery, Inc. which uses high intensity focused ultrasound technology to destroy deep-seated cancerous tissues without affecting surrounding healthy tissue. Misonix acquired worldwide rights to use the Focus technology in kidney, liver and breast treatment. Addressing a combined market estimated to be in excess of billion annually, Misonix's proprietary ultrasonic medical devices are used for wound debridement, cosmetic surgery, neurosurgery, laparoscopic surgery, and other surgical and medical applications. Misonix Inc. has a market cap of $12.2 million; its shares were traded at around $1.7401 with and P/S ratio of 0.3.
Insiders' Positions with MSON
- Buy:: VP R&D and Engineering Daniel Voic bought 631 shares of MSON stock on 11/16/2009 at the average price of 2, the price of the stock has decreased by 13% since
- Buy:: VP R&D and Engineering Daniel Voic bought 744 shares of MSON stock on 08/03/2009 at the average price of 1.69, the price of the stock has increased by 2.96% since
- Buy:: VP R&D and Engineering Daniel Voic bought 631 shares of MSON stock on 07/02/2009 at the average price of 2, the price of the stock has decreased by 13% since
- Buy:: VP R&D and Engineering Daniel Voic bought 631 shares of MSON stock on 06/23/2009 at the average price of 2, the price of the stock has decreased by 13% since
- Sell:: Director Howard Alliger sold 50,000 shares of MSON stock on 10/07/2009 at the average price of 2.39, the price of the stock has decreased by 27.19% since
